Search by Drug Name or NDC
NDC 31722-0981-31 Succinylcholine Chloride 20 mg/mL Details
Succinylcholine Chloride 20 mg/mL
Succinylcholine Chloride is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is SUCCINYLCHOLINE CHLORIDE.
Product Information
| NDC | 31722-0981 |
|---|---|
| Product ID | 31722-981_f53099bb-c2d6-4dd2-e053-2a95a90a6db5 |
| Associated GPIs | 74100010102005 |
| GCN Sequence Number | 004676 |
| GCN Sequence Number Description | succinylcholine chloride VIAL 20 MG/ML INJECTION |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 17992 |
| HICL Sequence Number | 001948 |
| HICL Sequence Number Description | SUCCINYLCHOLINE CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Succinylcholine Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Succinylcholine Chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | SUCCINYLCHOLINE CHLORIDE |
| Labeler Name | Camber Pharmaceuticals, Inc. |
| Pharmaceutical Class | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213810 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 31722-0981-31 (31722098131)
| NDC Package Code | 31722-981-31 |
|---|---|
| Billing NDC | 31722098131 |
| Package | 25 VIAL, MULTI-DOSE in 1 CARTON (31722-981-31) / 10 mL in 1 VIAL, MULTI-DOSE (31722-981-10) |
| Marketing Start Date | 2020-05-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |